comprehensive addiction treatment approaches – Science

Rising Polysubstance Use in Youth Opioid Overdoses Correlates with Age

SCIENMAG — Mon, 25 Aug 2025 19:24:19 +0000

In recent years, the United States has witnessed a disturbing evolution in the opioid overdose crisis, particularly among younger populations. While previous research has largely focused on adults aged 25 to 54 as the primary victims of opioid overdoses involving multiple substances, a groundbreaking study led by Boston University School of Public Health (BUSPH) in collaboration with Mass General Brigham for Children reveals a critical shift. New evidence now shows that polysubstance-involved opioid overdoses — overdoses where opioids are combined with other drugs — are alarmingly prevalent among youth aged 15 to 24. This revelation signals a disturbing expansion of the opioid epidemic’s reach into the younger demographic, amplifying the urgency for tailored prevention and treatment strategies.

Published recently in the esteemed medical journal Pediatrics, this extensive observational study analyzed federal overdose mortality data from 2020 through 2023. The findings expose a sobering trend: starting as early as age 15, polysubstance opioid overdoses have increased steadily with age among youth, surpassing opioid-only overdoses from age 21 onward. A startling 93% of these fatal overdoses involved fentanyl or other synthetic opioids, underscoring the deadly potency of the modern drug supply. In parallel, stimulants such as methamphetamine and cocaine consistently emerged as predominant contributors within these polysubstance events, highlighting a toxic convergence of substances driving youth mortality.

Historically, opioid overdose waves in the United States have unfolded in distinct phases. The 1990s witnessed the initial surge fueled primarily by prescription opioids. This was followed by a heroin-driven crisis around 2010, and more recently, a fentanyl and synthetic opioid-centered wave beginning in 2013. The current fourth wave, as described by the study’s lead author Connor Buchholz, a doctoral candidate in health services and policy research at BUSPH, is characterized by the lethal combination of synthetic opioids and stimulants. This new phase reflects an intersection of pharmacological hazards, where youth are increasingly exposed to unpredictable drug mixtures that exacerbate overdose risk.

The scale of this crisis among youth is staggering. The study reports nearly 23,000 opioid overdose fatalities in individuals aged 15 to 24 between 2020 and 2023. Approximately half of these deaths involved polysubstance use, with stimulants playing a central role in 65% of polysubstance opioid overdose deaths and 33% of all opioid overdose deaths in this age group. These statistics starkly illustrate that youth overdose mortality cannot be understood or addressed solely through the lens of opioids, but must incorporate the vital context of co-occurring stimulant use.

Age stratification within the study further reveals a progressive rise in polysubstance involvement with advancing youth age. Polysubstance opioid overdose deaths constituted 25% of fatalities among 15-year-olds, escalating to 40% among 18-year-olds, 53% in 21-year-olds, and peaking at 58% among 24-year-olds. Similarly, stimulant involvement grew from 12% in the youngest bracket to 41% among the oldest youth studied. This age-linked trajectory implies complex behavioral and environmental factors, possibly related to drug availability and evolving patterns of use, intensifying the overdose risk as adolescents transition into early adulthood.

The study refrains from explicitly dissecting all causal factors behind this age-related increase but points to several plausible drivers. Chief among these are the expanding availability of illicit and highly potent synthetic substances in the drug market, which heightens the risk of unintended exposure. Equally significant is the rise in mental health challenges among youth, including increasing diagnoses of attention-deficit/hyperactivity disorder (ADHD) and other psychological conditions that may compel some to self-medicate through substance use. These converging elements likely catalyze the shift towards polysubstance consumption patterns, complicating prevention efforts.

The contamination of counterfeit pills with fentanyl compounds the dangers for youth, even as opioid prescriptions have decreased. Pills masquerading as legitimate prescription medications—such as oxycodone or benzodiazepines—pose an insidious threat because they often contain lethal doses of synthetic opioids without the user’s knowledge. This covert presence of fentanyl in the drug supply underscores the need for heightened drug education, harm reduction approaches, and broader access to overdose reversal interventions tailored specifically for youth populations.

Adding to the challenge, recent federal policy decisions threaten to exacerbate this public health emergency. The study highlights concerns regarding impending cuts to Medicaid funding, a primary source of medical coverage for youth struggling with opioid use disorder (OUD). Such budget reductions risk restricting access to evidence-based medications for OUD, including buprenorphine, methadone, and naltrexone, which have proven efficacy in mitigating overdose risk. Moreover, reduced funding may limit the availability of naloxone (commonly known by the brand name Narcan) distribution programs, critical life-saving tools for first responders and communities grappling with opioid crises.

Dr. Scott Hadland, chief of the Division of Adolescent and Young Adult Medicine at Mass General Brigham for Children and senior author of the study, underscores the necessity of early, developmentally appropriate intervention. He notes that youth and their families depend heavily on Medicaid-supported treatments, and that timely access to comprehensive care can significantly alter the trajectory of opioid addiction and overdose risk. Hadland also warns that budgetary constraints threaten the ongoing progress made in combatting opioid fatalities among young people.

In response to these emerging realities, clinicians are urged to embrace holistic, nonstigmatizing approaches tailored to the unique needs of youth with OUD and stimulant use disorders (StUD). Dr. Buchholz emphasizes adherence to evolving clinical practice guidelines from leading U.S. medical organizations that advocate for integrated treatment modalities. These include both pharmacological options and behavioral interventions, underscoring that addressing polysubstance overdose risk requires multifaceted strategies.

Education remains a cornerstone of effective intervention, particularly regarding overdose prevention measures like naloxone administration. The study advocates expanding comprehensive training for healthcare providers who work with at-risk youth, enabling them to deliver life-saving overdose reversal techniques promptly and competently. For stimulant-related disorders, where FDA-approved pharmacotherapies are limited, the use of off-label medications alongside contingency management and behavioral therapies offers promising avenues, although continued research is essential.

Ultimately, this study serves as a critical wake-up call: the opioid crisis among American youth is no longer a single-substance epidemic but a complex polysubstance emergency that demands urgent, innovative responses. Understanding the nuanced role that synthetic opioids and stimulants play in this evolving landscape is vital to developing strategies that save lives. As the epidemic enters this perilous fourth wave, public health officials, clinicians, policymakers, and communities must collaborate on comprehensive, youth-centered solutions to reverse the tide of overdose deaths.

Subject of Research: People

Article Title: Polysubstance-Involved Opioid Overdose Deaths Among US Youths: 2020 to 2023

News Publication Date: August 25, 2025

Web References:

References: 10.1542/peds.2024-070433

Keywords: Stimulants, Drug addiction, Narcotics addiction, Substance related disorders, Opioid addiction, Children, Adolescents, Substance abuse, Drug abuse, Illicit drugs, Cocaine, Heroin, Public health, Insurance

Positive Experiences Reduce Drug-Seeking Behavior by Rewiring the Brain’s Dopamine System

SCIENMAG — Tue, 13 May 2025 17:41:12 +0000

In a landmark study published in Nature Neuroscience, researchers at the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, have shed new light on the intricate relationship between social hierarchy and vulnerability to drug addiction. Led by Professor ZHU Yingjie, this cutting-edge investigation uncovers the neural substrates linking social rank, dopamine circuit dynamics, and methamphetamine-seeking behavior in male rodents. By employing a comprehensive suite of sophisticated experimental techniques, the team elucidates how social status modulates addiction risk at the neurobiological level—a revelation that could pave the way for transformative approaches in addiction therapy.

Drug addiction remains one of the paramount global health crises, claiming millions of lives annually and posing serious challenges to public health systems worldwide. Despite decades of research, current therapeutic interventions yield limited success, often failing to address the underlying neurobiological vulnerabilities that predispose individuals to compulsive drug use. One clinical observation that has persisted over time is the influence of social rank on addiction susceptibility; individuals with lower social status frequently exhibit higher addiction rates. Yet the neural mechanisms behind this phenomenon have eluded scientific understanding—until now.

To unravel this complex interplay, Professor ZHU’s team utilized a multifaceted experimental strategy involving fiber photometry, fast-scan cyclic voltammetry (FSCV), optogenetic manipulation, and three-dimensional volumetric imaging through VISoR technology. These high-resolution tools allowed for in vivo monitoring and modulation of dopamine signaling pathways in distinct brain regions of male rodents differentiated by social dominance, thereby providing unprecedented insight into the functional architecture of addiction-related circuits.

Central to the researchers’ findings is the differential modulation of two critical dopaminergic pathways: the mesolimbic and mesocortical circuits. The mesolimbic pathway, projecting dopamine to the nucleus accumbens (NAc), functions as a reward hub that promotes drug-seeking behavior by reinforcing pleasurable stimuli. In contrast, the mesocortical pathway extends to the medial prefrontal cortex (mPFC), a region implicated in executive function and cognitive control, which serves as a neural “brake” to inhibit compulsive substance use. The balance between these dual pathways determines the brain’s overall vulnerability to addiction.

Intriguingly, the study reveals that low-ranking male rodents possess a hyperactive mesolimbic reward system coupled with a comparatively weakened mesocortical control network. This imbalance manifests as heightened susceptibility to methamphetamine (METH) seeking, conceptualized metaphorically by Professor ZHU as "a high-powered car with faulty brakes." Conversely, dominant males maintain a more evenly tuned dopamine circuit, enabling robust cognitive control to counteract drug-seeking impulses and thus exhibit resilience to addiction.

To establish causality, the researchers engaged cutting-edge optogenetic and pharmacological interventions to selectively manipulate dopamine signaling within these pathways. Suppression of dopamine-related proteins in the NAc of subordinate males attenuated METH consumption, reinforcing the role of mesolimbic hyperactivity in addictive behaviors. Conversely, targeted disruption of dopaminergic fibers within the mPFC of dominant males led to increased drug-seeking, effectively tipping the balance toward vulnerability. Remarkably, optogenetic activation of the mesocortical pathway not only suppressed METH intake but also enhanced social dominance itself, illustrating the bidirectional interaction between neural circuitry and social behavior.

Sex differences emerged as a crucial dimension in this research. Female rodents displayed METH-seeking behavior independent of social rank, a finding that underscores the existence of distinct neurobiological pathways governing addiction risk across sexes. This nuance points to a complex, multifactorial etiology of substance use disorders that likely requires sex-specific therapeutic strategies.

Further advancing their investigation, the team induced “winning experiences” in low-ranking males, simulating social ascendency through controlled behavioral paradigms. These artificially elevated social experiences triggered a consequential remodeling of both mesolimbic and mesocortical dopamine circuits, effectively elevating the animals’ social status and concurrently reducing drug-seeking behavior. The neural plasticity underlying these changes highlights the remarkable capacity of environmental and experiential factors to recalibrate addiction vulnerability.

Collectively, these results establish a novel neurobiological framework that contextualizes addiction susceptibility within the dynamics of social hierarchy and dopamine circuitry. Professor ZHU posits that enhancing an individual’s subjective sense of social accomplishment—or mimicking the neural impact of such successes—might represent an innovative, non-pharmacological avenue for addiction prevention. “Strengthening the neural brakes while attenuating the accelerator could recalibrate the balance of dopamine pathways to reduce compulsive drug-seeking,” he explains.

This groundbreaking research holds profound implications for the future of addiction treatment. By delineating the opposing roles of mesolimbic and mesocortical dopamine circuits in relation to social rank, the findings open the door to targeted neural modulation strategies. Such approaches may include non-invasive stimulation techniques tailored to boost executive control circuits or dampen maladaptive reward drives, ultimately offering a personalized method to combat substance use disorders.

Ultimately, the study by Professor ZHU and colleagues transcends traditional addiction models by situating vulnerability within the broader social context, elevating our understanding of how environmental and neurobiological factors converge. As the global burden of drug addiction escalates, interventions inspired by these insights may herald a new era of precision neuroscience-based therapies, transforming hope into tangible recovery pathways.

Subject of Research: Animals
Article Title: Social rank modulates methamphetamine-seeking in dominant and subordinate male rodents via distinct dopaminergic pathways
News Publication Date: 12-May-2025
Web References: https://www.nature.com/articles/s41593-025-01951-0
References: 10.1038/s41593-025-01951-0
Image Credits: SIAT
Keywords: dopamine pathways, addiction vulnerability, social rank, methamphetamine, mesolimbic circuit, mesocortical circuit, optogenetics, neural plasticity, addiction neuroscience, substance use disorder, executive control, reward system